Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.690
-0.080 (-1.68%)
At close: Apr 28, 2026, 4:00 PM EDT
4.660
-0.030 (-0.64%)
After-hours: Apr 28, 2026, 4:42 PM EDT
Bicycle Therapeutics Employees
Bicycle Therapeutics had 288 employees as of December 31, 2025. The number of employees decreased by 17 or -5.57% compared to the previous year.
Employees
288
Change (1Y)
-17
Growth (1Y)
-5.57%
Revenue / Employee
$252,035
Profits / Employee
-$760,278
Market Cap
326.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 156 |
| Nautilus Biotechnology | 130 |
| Rezolute | 75 |
| Surrozen | 44 |
| DiaMedica Therapeutics | 35 |
| Inhibikase Therapeutics | 35 |
| Ovid Therapeutics | 23 |
| Monopar Therapeutics | 22 |
BCYC News
- 7 days ago - Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting - Business Wire
- 8 days ago - Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026 - Business Wire
- 5 weeks ago - Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026 - Business Wire
- 6 weeks ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 3 months ago - Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline - Business Wire
- 3 months ago - Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 - Business Wire
- 4 months ago - Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline - Business Wire
- 5 months ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire